Pages that link to "Q39872186"

The following pages link to Imaging nanoprobe for prediction of outcome of nanoparticle chemotherapy by using mammography. (Q39872186):

Displaying 43 items.

• Challenges and strategies in anti-cancer nanomedicine development: An industry perspective (Q26748018) (← links)
• Targeted nanotechnology for cancer imaging (Q27010317) (← links)
• X-ray-computed tomography contrast agents (Q28280706) (← links)
• Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine (Q28391849) (← links)
• A mathematical model of the enhanced permeability and retention effect for liposome transport in solid tumors (Q28535613) (← links)
• Heterogeneous Uptake of Nanoparticles in Mouse Models of Pediatric High-Risk Neuroblastoma (Q28553602) (← links)
• Computed tomography imaging of primary lung cancer in mice using a liposomal-iodinated contrast agent (Q28730801) (← links)
• Cerebral vascular leak in a mouse model of amyloid neuropathology. (Q30609094) (← links)
• Selective targeting of nanocarriers to neutrophils and monocytes. (Q33433964) (← links)
• Tumor vascular permeability to a nanoprobe correlates to tumor-specific expression levels of angiogenic markers (Q33464944) (← links)
• Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticles (Q33755231) (← links)
• Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. (Q34447986) (← links)
• Evaluation of tumor microenvironment in an animal model using a nanoparticle contrast agent in computed tomography imaging (Q34470473) (← links)
• Inorganic nanoparticle-based contrast agents for molecular imaging (Q34644628) (← links)
• A multifunctional nanoplatform for imaging, radiotherapy, and the prediction of therapeutic response (Q35085021) (← links)
• Dual-energy micro-CT functional imaging of primary lung cancer in mice using gold and iodine nanoparticle contrast agents: a validation study (Q35092707) (← links)
• Whole-body organ-level and kidney micro-dosimetric evaluations of (64)Cu-loaded HER2/ErbB2-targeted liposomal doxorubicin ((64)Cu-MM-302) in rodents and primates. (Q35502131) (← links)
• Vascular Targeting of a Gold Nanoparticle to Breast Cancer Metastasis (Q35858759) (← links)
• Neuroimaging in Alzheimer's disease: preclinical challenges toward clinical efficacy (Q35975904) (← links)
• Enhanced delivery of chemotherapy to tumors using a multicomponent nanochain with radio-frequency-tunable drug release (Q35981121) (← links)
• Spatiotemporal Targeting of a Dual-Ligand Nanoparticle to Cancer Metastasis. (Q36084803) (← links)
• High-resolution CT vascular imaging using blood pool contrast agents. (Q36119292) (← links)
• Imaging metastasis using an integrin-targeting chain-shaped nanoparticle (Q36366404) (← links)
• The effects of particle size, density and shape on margination of nanoparticles in microcirculation (Q36488910) (← links)
• Multimodal in vivo imaging exposes the voyage of nanoparticles in tumor microcirculation. (Q36807158) (← links)
• In vivo characterization of tumor vasculature using iodine and gold nanoparticles and dual energy micro-CT. (Q37102305) (← links)
• Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles (Q37476252) (← links)
• Multimodal Magnetic Resonance and Near-Infrared-Fluorescent Imaging of Intraperitoneal Ovarian Cancer Using a Dual-Mode-Dual-Gadolinium Liposomal Contrast Agent. (Q37526228) (← links)
• Nano-sized CT contrast agents. (Q38095868) (← links)
• Nanotechnology for computed tomography: a real potential recently disclosed. (Q38125076) (← links)
• Improved Targeting of Cancers with Nanotherapeutics (Q39114835) (← links)
• Rethinking cancer nanotheranostics (Q42640884) (← links)
• Multiscale kinetic modeling of liposomal Doxorubicin delivery quantifies the role of tumor and drug-specific parameters in local delivery to tumors (Q43226325) (← links)
• 64Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer. (Q46097998) (← links)
• Big Potential from Small Agents: Nanoparticles for Imaging-Based Companion Diagnostics (Q50422486) (← links)
• Polymer Therapeutics: Biomarkers and New Approaches for Personalized Cancer Treatment. (Q52707854) (← links)
• Companion Diagnostic 64Cu-Liposome Positron Emission Tomography Enables Characterization of Drug Delivery to Tumors and Predicts Response to Cancer Nanomedicines. (Q55265623) (← links)
• Nanoparticles in Daily Life: Applications, Toxicity and Regulations (Q57498362) (← links)
• Imaging breast cancer using a dual-ligand nanochain particle (Q58602364) (← links)
• Cancer nanomedicines: closing the translational gap (Q86607263) (← links)
• Precise targeting of cancer metastasis using multi-ligand nanoparticles incorporating four different ligands (Q88273760) (← links)
• Prediction of Anti-cancer Nanotherapy Efficacy by Imaging (Q89736571) (← links)
• Effective treatment of cancer metastasis using a dual-ligand nanoparticle (Q92252053) (← links)